255 related articles for article (PubMed ID: 31896234)
1. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway.
Kim K; Kim JH; Kim I; Seong S; Kim N
Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234
[TBL] [Abstract][Full Text] [Related]
2. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
[TBL] [Abstract][Full Text] [Related]
3. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
4. REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output.
Ikeda R; Tsuchiya Y; Koike N; Umemura Y; Inokawa H; Ono R; Inoue M; Sasawaki Y; Grieten T; Okubo N; Ikoma K; Fujiwara H; Kubo T; Yagita K
Sci Rep; 2019 Jul; 9(1):10171. PubMed ID: 31308426
[TBL] [Abstract][Full Text] [Related]
5. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
6. TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation.
Kim K; Kim JH; Kim I; Seong S; Kim N
Bone; 2018 Aug; 113():17-28. PubMed ID: 29753717
[TBL] [Abstract][Full Text] [Related]
7. Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function.
Bugge A; Feng D; Everett LJ; Briggs ER; Mullican SE; Wang F; Jager J; Lazar MA
Genes Dev; 2012 Apr; 26(7):657-67. PubMed ID: 22474260
[TBL] [Abstract][Full Text] [Related]
8. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
Shim KS; Lee B; Ma JY
BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
10. REV-ERBs negatively regulate mineralization of the cementoblasts.
Fu L; Wang M; Zhu G; Zhao Z; Sun H; Cao Z; Xia H
Biochem Biophys Res Commun; 2022 Jan; 587():9-15. PubMed ID: 34861472
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
[TBL] [Abstract][Full Text] [Related]
12. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
13. Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.
Park KH; Gu DR; So HS; Kim KJ; Lee SH
J Dent Res; 2015 Dec; 94(12):1676-83. PubMed ID: 26350961
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
16. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation and genetic deletion of REV-ERBα and REV-ERBβ regulates dendritic cell development.
Amir M; Campbell S; Kamenecka TM; Solt LA
Biochem Biophys Res Commun; 2020 Jul; 527(4):1000-1007. PubMed ID: 32439175
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
20. p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
He J; Liu Z; Zheng Y; Qian J; Li H; Lu Y; Xu J; Hong B; Zhang M; Lin P; Cai Z; Orlowski RZ; Kwak LW; Yi Q; Yang J
Cancer Res; 2012 Dec; 72(24):6393-402. PubMed ID: 23066034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
